Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Christensen, D. H., Nicolaisen, S. K., Ahlqvist, E., Stidsen, J. V., Nielsen, J. S., Hojlund, K., Olsen, M. H., García-Calzón, S., Ling, C., Rungby, J., Brandslund, I., Vestergaard, P., Jessen, N., Hansen, T., Brøns, C., Beck-Nielsen, H., Sørensen, H. T., Thomsen, R. W. & Vaag, A. (2022). Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort. BMJ Open Diabetes Research & Care, 10(2), Article e002731. https://doi.org/10.1136/bmjdrc-2021-002731

Starup-Linde, J., Hygum, K., Harsløf, T. & Langdahl, B. (2019). Type 1 Diabetes and Bone Fragility: Links and Risks. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 2539-2547. https://doi.org/10.2147/DMSO.S191091

Jørgensen, A. P., Ueland, T., Sode-Carlsen, R., Schreiner, T., Rabben, K. F., Farholt, S., Høybye, C., Christiansen, J. S. & Bollerslev, J. (2013). Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD. Journal of Clinical Endocrinology and Metabolism, 98(4), E753-60. https://doi.org/10.1210/jc.2012-3378

Birkebæk, N. & Lildballe, D. L. (2023). Two male siblings with extremely tall stature, moderate mental retardation and a deletion of ASH1L at chromosome 1q22. Hormone Research in Paediatrics, 96(Suppl. 4). https://doi.org/10.1159/000533803

Franek, E., Haluzík, M., Canecki Varžić, S., Sargin, M., Macura, S., Zacho, J. & Christiansen, J. S. (2016). Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes. Diabetic Medicine, 33(4), 497-505. https://doi.org/10.1111/dme.12982

Christiansen, J. S., Vaz, J. A., Metelko, Z., Bogoev, M. & Dedov, I. (2003). Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 5(6), 446-454.

Mogensen, C. E. (2008). Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Research and Clinical Practice, 82 Suppl 1, S2-9. https://doi.org/10.1016/j.diabres.2008.09.029

Krag, K. S. (2010). Turner syndrom - epidemiologi. In C. Gravholt (Ed.), Turner - kend din krop: En informationsbog om Turner syndrom (1 ed., pp. 94-99). Novo Nordisk.

Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K. & Andersen, N. H. (2019). Turner syndrome: mechanisms and management. Nature Reviews. Endocrinology, 15(10), 601-614. https://doi.org/10.1038/s41574-019-0224-4

Viuff, M. & Gravholt, C. H. (2022). Turner Syndrome and Fertility. Annales d'Endocrinologie, 83(4), 244-249. https://doi.org/10.1016/j.ando.2022.06.001

Displaying results 141 to 150 out of 4020

Revised 11.09.2025

Department of Clinical Medicine